Tabashnik, Bruce E.
Zhang, Min
Fabrick, Jeffrey A.
Wu, Yidong
Gao, Meijing
Huang, Fangneng
Wei, Jizhen
Zhang, Jie
Yelich, Alexander
Unnithan, Gopalan C.
Bravo, Alejandra
Soberón, Mario
Carrière, Yves
Li, Xianchun
Article History
Received: 17 August 2015
Accepted: 16 September 2015
First Online: 12 October 2015
Competing interests
: B.E.T., M.S. and A.B. are coauthors of a patent on modified Bt toxins, “Suppression of Resistance in Insects to <i>Bacillus thuringiensis</i> Cry Toxins, Using Toxins that do not Require the Cadherin Receptor” (patent numbers: CA2690188A1, CN101730712A, EP2184293A2, EP2184293A4, EP2184293B1, WO2008150150A2, WO2008150150A3). J.A.F. is coauthor of a patent “Cadherin Receptor Peptide for Potentiating Bt Biopesticides” (patent numbers: US20090175974A1, US8354371, WO2009067487A2, WO2009067487A3). Bayer CropScience, Dow AgroSciences, DuPont Pioneer, Monsanto and Syngenta did not provide funding to support this work, but may be affected financially by publication of this paper and have funded other work by some of the authors.